What Fueled The Previous Growth In The Transcatheter Valve Repair System Market?
The transcatheter valve repair system market has seen considerable growth due to a variety of factors.
•The market for the transcatheter valve repair system has been experiencing substantial growth in recent times, and the trend is projected to continue. Forecasts indicate an increase from $5.08 billion in 2024 to $5.48 billion in 2025, delivering a compound annual growth rate (CAGR) of 7.9%.
The significant growth recorded in the past can be associated with factors such as rising rates of cardiovascular diseases, limits in surgical options, the initial success of the transcatheter valve, substantial investment in research and development, and the adoption and training of physicians.
What Is The Expected Growth In The Transcatheter Valve Repair System Market Size?
The transcatheter valve repair system market is expected to maintain its strong growth trajectory in upcoming years.
• In the ensuing years, the market size for the transcatheter valve repair system is anticipated to witness impressive growth, expanding to $7.67 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 8.8%.
The accelerated growth in this forecast period can be credited to broader indications, an increasing elderly population, initiatives towards value-based health care, patient-focused care models, and the development of next-generation devices. The primary trends projected for this period encompass a focus on long-term durability, integration with the healthcare system, precision medicine driven by data, remote and robotic-aided interventions, and hybrid procedures.
What Main Forces Are Fueling Expansion In The Transcatheter Valve Repair System Market?
The escalating prevalence of cardiovascular ailments is set to boost the expansion of the transcatheter valve repair system market. This type of disease impacts blood vessels or the heart itself. Transcatheter instruments are utilized to substitute malfunctioning aortic valves with artificial ones in the medical management of valvular cardiac disease, specifically aortic valve disorders. For example, in the U.S in December 2022, data released by the New York government revealed that heart disease is responsible for approximately 697,000 deaths annually, equating to 1 in every 5 deaths. In this context, around 805,000 Americans suffer from heart attacks each year, with 605,000 experiencing their first heart attack and 200,000 due to recurrent episodes. Consequently, the increasing prevalence of heart disease is catalyzing the expansion of the transcatheter valve repair system market.
What Are The Primary Segments In The Global Transcatheter Valve Repair System Market?
The transcatheter valve repair system market covered in this report is segmented –
1) By Product Type: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), Transcatheter Pulmonary Valve Replacement (TPVR), Transcatheter Tricuspid Valve Replacement (TTVR)
2) By Application: Aortic Stenosis, Mitral Stenosis, Tricuspid Stenosis, Pulmonary Stenosis
3) By End-user: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Transcatheter Aortic Valve Replacement (TAVR): Self-Expandable TAVR Valves, Balloon-Expandable TAVR Valves, Mechanically Expanded TAVR Valves
2) By Transcatheter Mitral Valve Replacement (TMVR): Self-Expandable TMVR Devices, Balloon-Expandable TMVR Devices, Transcatheter Mitral Valve Repair Systems
3) By Transcatheter Pulmonary Valve Replacement (TPVR): Self-Expandable TPVR Valves, Balloon-Expandable TPVR Valves
4) By Transcatheter Tricuspid Valve Replacement (TTVR): Self-Expandable TTVR Devices, Balloon-Expandable TTVR Devices
Pre-Book The Transcatheter Valve Repair System Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Transcatheter Valve Repair System Market?
Product innovation is steadily becoming a significant trend in the transcatheter valve repair system market. Companies with a significant market presence are focusing their efforts on developing new products to strengthen their market standing. For instance, in December 2022, Abbott Laboratories Inc., a healthcare organization based in the US that offers a broad array of healthcare products, unveiled Navitor, its latest generation transcatheter aortic valve implantation (TAVI) system. With this move, the minimally invasive technology is now available to high-risk or extreme surgery risk patients in India suffering from severe aortic stenosis. Leveraging innovations such as a design that prevents blood leaks around the valve, the firm is pioneering TAVI therapies (also known as TAVR or transcatheter aortic valve replacement) with the Navitor valve.
Who Are the Key Players in the Transcatheter Valve Repair System Market?
Major companies operating in the transcatheter valve repair system market include:
• Abbott Laboratories
• Medtronic Plc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Bracco Group
• LivaNova Plc.
• Meril Life Sciences Pvt. Ltd.
• Cordis Corporation
• MicroPort Scientific Corporation.
• Biotronik Pvt. Ltd
• AtriCure Inc.
• OrbusNeich Medical Group Holdings Limited
• Venus Medtech (Hangzhou) Inc.
• Dura LLC
• HLT Medical Inc.
• Symetis SA
• JenaValve Technology Inc.
• 4C Medical Technologies Inc.
• Cardiac Dimensions Inc.
• Valve Solutions Inc.
• Transcatheter Technologies GmbH
• Evalve Corporation
• Colibri Heart Valve LLC
• Medtentia International Ltd.
• Coramaze Technologies Ltd.
• Neovasc Inc.
• Anteris Technologies Ltd.
What Is The Most Dominant Region In The Transcatheter Valve Repair System Market?
North America was the largest region in the transcatheter valve repair systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter valve repair system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
